Annual Shareholders Equity
$3.74 B
+$651.26 M+21.11%
December 31, 2023
Summary
- As of February 22, 2025, JAZZ annual stockholders equity is $3.74 billion, with the most recent change of +$651.26 million (+21.11%) on December 31, 2023.
- During the last 3 years, JAZZ annual shareholders equity has risen by +$77.25 million (+2.11%).
- JAZZ annual shareholders equity is now -5.75% below its all-time high of $3.97 billion, reached on December 31, 2021.
Performance
JAZZ Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$4.17 B
+$408.47 M+10.86%
September 30, 2024
Summary
- As of February 22, 2025, JAZZ quarterly stockholders equity is $4.17 billion, with the most recent change of +$408.47 million (+10.86%) on September 30, 2024.
- Over the past year, JAZZ quarterly shareholders equity has increased by +$681.69 million (+19.54%).
- JAZZ quarterly shareholders equity is now at all-time high.
Performance
JAZZ Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
JAZZ Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +21.1% | +19.5% |
| 3 y3 years | +2.1% | +19.5% |
| 5 y5 years | +35.5% | +19.5% |
JAZZ Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -5.8% | +21.1% | at high | +51.9% |
| 5 y | 5-year | -5.8% | +21.1% | at high | +51.9% |
| alltime | all time | -5.8% | +2219.7% | at high | +2465.9% |
Jazz Pharmaceuticals Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $4.17 B(+10.9%) |
| Jun 2024 | - | $3.76 B(+1.8%) |
| Mar 2024 | - | $3.70 B(-1.1%) |
| Dec 2023 | $3.74 B(+21.1%) | $3.74 B(+7.1%) |
| Sep 2023 | - | $3.49 B(-1.0%) |
| Jun 2023 | - | $3.53 B(+5.7%) |
| Mar 2023 | - | $3.34 B(+8.1%) |
| Dec 2022 | $3.09 B(-22.2%) | $3.09 B(+12.4%) |
| Sep 2022 | - | $2.75 B(-14.2%) |
| Jun 2022 | - | $3.20 B(-11.3%) |
| Mar 2022 | - | $3.61 B(-9.0%) |
| Dec 2021 | $3.97 B(+8.3%) | $3.97 B(+0.7%) |
| Sep 2021 | - | $3.94 B(-4.7%) |
| Jun 2021 | - | $4.13 B(+8.8%) |
| Mar 2021 | - | $3.80 B(+3.8%) |
| Dec 2020 | $3.66 B(+17.6%) | $3.66 B(+8.4%) |
| Sep 2020 | - | $3.38 B(+7.5%) |
| Jun 2020 | - | $3.14 B(+11.9%) |
| Mar 2020 | - | $2.81 B(-9.7%) |
| Dec 2019 | $3.11 B(+12.8%) | $3.11 B(+1.9%) |
| Sep 2019 | - | $3.05 B(+2.4%) |
| Jun 2019 | - | $2.98 B(+9.3%) |
| Mar 2019 | - | $2.73 B(-1.0%) |
| Dec 2018 | $2.76 B(+1.6%) | $2.76 B(-8.9%) |
| Sep 2018 | - | $3.03 B(+5.5%) |
| Jun 2018 | - | $2.87 B(+3.0%) |
| Mar 2018 | - | $2.79 B(+2.7%) |
| Dec 2017 | $2.71 B(+44.5%) | $2.71 B(+9.9%) |
| Sep 2017 | - | $2.47 B(+12.2%) |
| Jun 2017 | - | $2.20 B(+10.9%) |
| Mar 2017 | - | $1.98 B(+5.7%) |
| Dec 2016 | $1.88 B(+17.4%) | $1.88 B(+9.4%) |
| Sep 2016 | - | $1.72 B(+1.4%) |
| Jun 2016 | - | $1.69 B(+5.3%) |
| Mar 2016 | - | $1.61 B(+0.6%) |
| Dec 2015 | $1.60 B | $1.60 B(+2.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2015 | - | $1.56 B(+8.1%) |
| Jun 2015 | - | $1.45 B(+10.8%) |
| Mar 2015 | - | $1.31 B(-4.8%) |
| Dec 2014 | $1.37 B(+5.8%) | $1.37 B(+2.3%) |
| Sep 2014 | - | $1.34 B(+4.8%) |
| Jun 2014 | - | $1.28 B(+2.5%) |
| Mar 2014 | - | $1.25 B(-3.6%) |
| Dec 2013 | $1.30 B(+15.5%) | $1.30 B(+4.2%) |
| Sep 2013 | - | $1.24 B(+5.8%) |
| Jun 2013 | - | $1.18 B(+1.2%) |
| Mar 2013 | - | $1.16 B(+3.6%) |
| Dec 2012 | $1.12 B(+481.6%) | $1.12 B(+26.5%) |
| Sep 2012 | - | $886.09 M(+6.6%) |
| Jun 2012 | - | $831.46 M(+6.3%) |
| Mar 2012 | - | $781.83 M(+305.5%) |
| Dec 2011 | $192.79 M(+531.0%) | $192.79 M(+36.4%) |
| Sep 2011 | - | $141.33 M(+39.1%) |
| Jun 2011 | - | $101.60 M(+69.1%) |
| Mar 2011 | - | $60.07 M(+96.6%) |
| Dec 2010 | $30.55 M(-141.9%) | $30.55 M(-287.4%) |
| Jun 2010 | - | -$16.30 M(-76.4%) |
| Mar 2010 | - | -$69.00 M(-5.3%) |
| Dec 2009 | -$72.83 M(-21.6%) | -$72.83 M(-11.7%) |
| Sep 2009 | - | -$82.44 M(-7.3%) |
| Jun 2009 | - | -$88.90 M(-3.7%) |
| Mar 2009 | - | -$92.30 M(-0.6%) |
| Dec 2008 | -$92.88 M(-268.9%) | -$92.88 M(+143.3%) |
| Sep 2008 | - | -$38.18 M(+7.2%) |
| Jun 2008 | - | -$35.62 M(-386.3%) |
| Mar 2008 | - | $12.44 M(-77.4%) |
| Dec 2007 | $54.99 M(-131.2%) | $54.99 M(-50.8%) |
| Sep 2007 | - | $111.69 M(-13.5%) |
| Jun 2007 | - | $129.08 M(+70.3%) |
| Mar 2007 | - | $75.81 M(-143.0%) |
| Dec 2006 | -$176.30 M(+49.1%) | -$176.30 M(+49.1%) |
| Dec 2005 | -$118.25 M | -$118.25 M |
FAQ
- What is Jazz Pharmaceuticals annual stockholders equity?
- What is the all time high annual shareholders equity for Jazz Pharmaceuticals?
- What is Jazz Pharmaceuticals annual shareholders equity year-on-year change?
- What is Jazz Pharmaceuticals quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Jazz Pharmaceuticals?
- What is Jazz Pharmaceuticals quarterly shareholders equity year-on-year change?
What is Jazz Pharmaceuticals annual stockholders equity?
The current annual shareholders equity of JAZZ is $3.74 B
What is the all time high annual shareholders equity for Jazz Pharmaceuticals?
Jazz Pharmaceuticals all-time high annual stockholders equity is $3.97 B
What is Jazz Pharmaceuticals annual shareholders equity year-on-year change?
Over the past year, JAZZ annual stockholders equity has changed by +$651.26 M (+21.11%)
What is Jazz Pharmaceuticals quarterly stockholders equity?
The current quarterly shareholders equity of JAZZ is $4.17 B
What is the all time high quarterly shareholders equity for Jazz Pharmaceuticals?
Jazz Pharmaceuticals all-time high quarterly stockholders equity is $4.17 B
What is Jazz Pharmaceuticals quarterly shareholders equity year-on-year change?
Over the past year, JAZZ quarterly stockholders equity has changed by +$681.69 M (+19.54%)